ATE354095T1 - Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand - Google Patents

Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand

Info

Publication number
ATE354095T1
ATE354095T1 AT03799682T AT03799682T ATE354095T1 AT E354095 T1 ATE354095 T1 AT E354095T1 AT 03799682 T AT03799682 T AT 03799682T AT 03799682 T AT03799682 T AT 03799682T AT E354095 T1 ATE354095 T1 AT E354095T1
Authority
AT
Austria
Prior art keywords
prpsc
macrocyclic ligand
detecting prp
immunodetection
mal
Prior art date
Application number
AT03799682T
Other languages
English (en)
Inventor
Aly Moussa
Anthony William Coleman
Patrick Shahgaldian
Silva Eric Da
Ambroise Martin
Adina Nicoleta Lazar
Edwige Leclere
Marilyne Dupin
Herve Perron
Original Assignee
Afssa
Centre Nat Rech Scient
Univ Claude Bernard Lyon
Biomerieux Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Afssa, Centre Nat Rech Scient, Univ Claude Bernard Lyon, Biomerieux Sa filed Critical Afssa
Application granted granted Critical
Publication of ATE354095T1 publication Critical patent/ATE354095T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/823—Immunogenic carrier or carrier per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/807—Hapten conjugated with peptide or protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Transmission And Conversion Of Sensor Element Output (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT03799682T 2002-12-20 2003-12-19 Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand ATE354095T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0216383A FR2849205B1 (fr) 2002-12-20 2002-12-20 Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification

Publications (1)

Publication Number Publication Date
ATE354095T1 true ATE354095T1 (de) 2007-03-15

Family

ID=32406305

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03799682T ATE354095T1 (de) 2002-12-20 2003-12-19 Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand

Country Status (14)

Country Link
US (2) US7217530B2 (de)
EP (1) EP1573337B1 (de)
JP (1) JP2006510914A (de)
CN (1) CN100380125C (de)
AT (1) ATE354095T1 (de)
AU (1) AU2003299390B2 (de)
BR (1) BR0317080A (de)
DE (1) DE60311871T2 (de)
DK (1) DK1573337T3 (de)
ES (1) ES2282733T3 (de)
FR (1) FR2849205B1 (de)
MX (1) MXPA05006766A (de)
PT (1) PT1573337E (de)
WO (1) WO2004059322A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2849205B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification
DE10328125A1 (de) * 2003-06-23 2005-01-13 Roche Diagnostics Gmbh Nachweis von Protease-resistentem Prion-Protein nach spontaner Transformationsreaktion
FR2865280B1 (fr) * 2004-01-20 2007-01-12 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2865279A1 (fr) * 2004-01-20 2005-07-22 Biomerieux Sa Procede de detection de la prp utilisant une molecule ayant au moins une charge positive et/ou au moins une liaison osidique et un ligand autre qu'un ligand proteique
FR2888937B1 (fr) * 2005-07-21 2012-10-26 Biomerieux Sa Procede de detection des fcpa utilisant un agent d'agregation des fcpa et un agent de capture des agregats formes
EP2295969B1 (de) * 2008-07-04 2016-05-18 Sekisui Medical Co., Ltd. Verfahren zur erhöhung der sensitivität bzw. verfahren zur vermeidung des einflusses von hämoglobin auf immunologische messungen
WO2013091074A1 (en) * 2011-12-21 2013-06-27 Uvic Industry Partnerships Inc. Method and array for identifying histone-code-related analytes
US10338037B2 (en) 2015-08-18 2019-07-02 Uvic Industry Partnerships Inc. Compounds and conjugates for identifying and separating post-translationally modified analytes
CA3084887A1 (en) 2019-06-25 2020-12-25 Uvic Industry Partnerships Inc. Compound and dimer complex embodiments for supramolecular sensing
CN113876760B (zh) * 2021-10-26 2022-12-23 南开大学 杯芳烃和/或杯芳烃的衍生物在制备治疗创伤性脑损伤的药物中的应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312837A (en) * 1991-01-29 1994-05-17 Genelabs Technologies, Inc. Method of treating viral infections with aryl macrocyclic compounds
US5342934A (en) * 1992-06-19 1994-08-30 The Trustees Of Columbia University In The City Of New York Enantioselective receptor for amino acid derivatives, and other compounds
EP0891364A1 (de) * 1996-04-05 1999-01-20 The Board Of Regents, The University Of Texas System Calixpyrrole, calixpyridinopyrrole und calixpyridine
US6054114A (en) * 1996-05-08 2000-04-25 Massachusetts Institute Of Technology Organometallic ligands for the localization and quantification of amyloid in vivo and in vitro
US5891641A (en) * 1997-02-21 1999-04-06 The Regents Of The University Of California Assay for disease related conformation of a protein
US6150172A (en) * 1999-01-08 2000-11-21 The United States Of America As Represented By The Secretary Of Agriculture Method and kit for extracting prion protein
CA2385743A1 (en) * 1999-09-28 2001-04-05 Universitat Zurich Factors having prion-binding activity in serum and plasma and agents to detect transmissible spongiform encephalopathitis
AU2001251358A1 (en) * 2000-04-05 2001-10-23 V.I. Technologies, Inc. Prion-binding ligands and methods of using same
DE10107083C2 (de) * 2001-02-13 2003-02-20 Abdulgabar Salama Pentosan Polysulfat als Ligand zum Nachweis von Prionen
DE10119713A1 (de) * 2001-04-21 2002-10-24 Prionics Ag Zuerich Verfahren zur Untersuchung von Prion-Protein enthaltenden Proben auf das eventuelle Vorliegen der PrPSc-Form
FR2849205B1 (fr) * 2002-12-20 2005-02-11 Afssa Procede d'amplification de la detection de la prpsc et utilisation d'un ligand adjuvant macrocyclique pour une telle amplification

Also Published As

Publication number Publication date
US20060019311A1 (en) 2006-01-26
JP2006510914A (ja) 2006-03-30
ES2282733T3 (es) 2007-10-16
DK1573337T3 (da) 2007-06-11
US20070154885A1 (en) 2007-07-05
WO2004059322A8 (fr) 2005-07-14
FR2849205A1 (fr) 2004-06-25
CN100380125C (zh) 2008-04-09
DE60311871T2 (de) 2007-10-31
DE60311871D1 (de) 2007-03-29
BR0317080A (pt) 2005-10-25
CN1729397A (zh) 2006-02-01
PT1573337E (pt) 2007-05-31
FR2849205B1 (fr) 2005-02-11
EP1573337A1 (de) 2005-09-14
AU2003299390A1 (en) 2004-07-22
EP1573337B1 (de) 2007-02-14
US7217530B2 (en) 2007-05-15
MXPA05006766A (es) 2006-02-17
WO2004059322A1 (fr) 2004-07-15
AU2003299390A8 (en) 2004-07-22
AU2003299390B2 (en) 2007-11-01

Similar Documents

Publication Publication Date Title
DE59903915D1 (de) Verfahren zur frühen diagnose von carcinomen
DE60028040D1 (de) Annexin-proteine und auto-antikörper als serummarker für lungenkrebs und ösophaguskrebs
DK1953551T3 (da) Prion-proteinligander samt fremgangsmåder til anvendelse deraf
JOP20200216A1 (ar) تجارب للكشف عن التنكس العصبي
ATE416376T1 (de) Analysegeräte, biosensoren und verfahren
DE60326567D1 (de) Diagnose von hepatozellulärem karzinom
DE602007003833D1 (de) Verbesserte vitamin-d-messung
ATE438853T1 (de) Diagnostische testvorrichtung
ATE514950T1 (de) Verfahren zur untersuchung von sepsis bei menschen
ATE493649T1 (de) Verfahren zur diagnose von polyzystischer nierenkrankheit
DE60311871D1 (de) Verfahren zur detektion von prp unter verwendung ein makrozyklischen ligand
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
EP2074427A4 (de) Diagnostik-biomolekül(e)
DE60315715D1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DK2118666T3 (da) Fremgangsmåde til normalisering af koncentrationen af analytter i en urinprøve
ATE302410T1 (de) Verfahren und vorrichtung zur messung von blutgasparametern
ATE545460T1 (de) Proteomanalyseverfahren für phosphoryliertes protein
ATE514948T1 (de) In vitro verfahren zur diagnose von neurodegenerativen erkrankungen
DE60301821D1 (de) Küvette für ein Lesegerät zur Bestimmung von Substanzen mittels der Evaneszenzfeldmethode
FI20040255A7 (fi) Menetelmä pre-eklampsian riskin havaitsemiseksi
WO2007047029A3 (en) Alzheimer's disease-specific alterations of the erk1/erk2 phosphorylation ratio as alzheimer's disease-specific molecular biomarkers (adsmb)
ATE482398T1 (de) Verfahren zur stratifizierung von herzinsuffizienz
DE602004011228D1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
ATE557277T1 (de) Verfahren zur diagnose von endometriose mittels tfpi-2 protein
ATE398288T1 (de) Hoch-durchsatz prion tests

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties